Systematic serological testing for hepatitis e virus in kidney transplant recipients

Journal of Clinical Microbiology

Volumn 53, Issue 5, 2015, Pages 1523-1530

  Moal, Valérie ^a,b   Legris, Tristan ^a   Motte, Anne ^a   Vacher Coponat, Henri ^a,c   Fages, Lucie ^a   Jourde Chiche, Noémie ^a,c   Borentain, Patrick ^a   Jaubert, Dominique ^a,d   Gerolami, René ^a,c   Colson, Philippe ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b AIX MARSEILLE UNIVERSITÉ   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d CENTRE HOSPITALIER DU PAYS D AIX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; RIBAVIRIN; VIRUS RNA; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE HEPATITIS; ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FEMALE; FRANCE; HEPATITIS E; HEPATITIS E VIRUS; HEPATITIS E VIRUS GENOTYPE 3E; HEPATITIS E VIRUS GENOTYPE 3F; HEPATITIS E VIRUS GENOTYPE 3I; HUMAN; HYPERTRANSAMINASEMIA; IMMUNOLOGY TEST KIT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROPLATE ENZYME IMMUNOASSAY; MICROPLATE ENZYME IMMUNOASSAY KIT; MIDDLE AGED; PHYLOGENY; PRIORITY JOURNAL; RAW MEAT; SEROCONVERSION; SEROPREVALENCE; VIRUS LOAD; ADOLESCENT; ADVERSE EFFECTS; BLOOD; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; IMMUNOLOGY; MASS SCREENING; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

HEPATITIS E VIRUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRANCE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; KIDNEY TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; TRANSPLANT RECIPIENTS; YOUNG ADULT;

EID: 84928038907     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.03624-14     Document Type: Article

References (41)

1. Kaba M, Moal V, Gerolami R, Colson P. 2013. Epidemiology of mammalian hepatitis E virus infection. Intervirology 56:67-83. http://dx.doi .org/10.1159/000342301.
2. Kamar N, Dalton HR, Abravanel F, Izopet J. 2014. Hepatitis E virus infection. Clin Microbiol Rev 27:116-138. http://dx.doi.org/10.1128/CMR.00057-13.
3. Bouquet J, Tesse S, Lunazzi A, Eloit M, Rose N, Nicand E, Pavio N. 2011. Close similarity between sequences of hepatitis E virus recovered from humans and swine, France, 2008-2009. Emerg Infect Dis 17:2018-2025. http://dx.doi.org/10.3201/eid1711.110616.
4. Kamar N, Selves J, Mansuy JM, Ouezzani L, Peron JM, Guitard J, Cointault O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J, Rostaing L. 2008. Hepatitis E virus and chronic hepatitis in organ-transplant recipients.NEngl J Med 358:811-817. http://dx.doi.org/10.1056/NEJMoa0706992.
5. Gérolami R, Moal V, Colson P. 2008. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient.NEngl J Med 358:859-860. http://dx.doi .org/10.1056/NEJMc0708687.
6. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. 2009. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 361:1025-1027. http://dx.doi.org/10.1056/NEJMc0903778.
7. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gerolami R. 2011. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 18:227-228. http://dx.doi.org/10.1111/j .1365-2893.2010.01311.x.
8. Ollier L, Tieulie N, Sanderson F, Heudier P, Giordanengo V, Fuzibet JG, Nicand E. 2009. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 150:430-431. http://dx.doi.org/10.7326/0003-4819-150-6-200903170-00025.
9. Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. 2010. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 153:135-136. http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00256.
10. Honer zu Siederdissen C, Pischke S, Schlue J, Deterding K, Hellms T, Schuler-Luttmann S, Schwarz A, Manns MP, Cornberg M, Wedemeyer H. 2014. Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection. Hepatology 60:1112-1113. http://dx.doi.org/10.1002/hep.26987.
11. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR. 2012. Hepatitis E. Lancet 379:2477-2488. http://dx.doi.org/10.1016/S0140-6736(11)61849-7.
12. Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B, Garcia S, Motte A, Gerolami R, Berland Y, Colson P. 2013. Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 85:462-471. http://dx.doi.org/10.1002/jmv.23469.
13. Gallian P, Lhomme S, Piquet Y, Saune K, Abravanel F, Assal A, Tiberghien P, Izopet J. 2014. Hepatitis E virus infections in blood donors, France. Emerg Infect Dis 20:1914-1917. http://dx.doi.org/10.3201/eid2011.140516.
14. Pavio N, Merbah T, Thebault A. 2014. Frequent hepatitis E virus contamination in food containing raw pork liver, France. Emerg Infect Dis 20:1925-1927. http://dx.doi.org/10.3201/eid2011.140891.
15. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. 2010. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 202:825-834. http://dx.doi.org/10.1086/655898.
16. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. 2002. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol 40:117-122. http://dx.doi.org/10.1128/JCM.40.1.117-122.2002.
17. Lewis HC, Wichmann O, Duizer E. 2010. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 138:145-166. http://dx.doi.org/10.1017/S0950268809990847.
18. Wichmann O, Schimanski S, Koch J, Kohler M, Rothe C, Plentz A, Jilg W, Stark K. 2008. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 198:1732-1741. http://dx.doi.org/10 .1086/593211.
19. Mansuy JM, Bendall R, Legrand-Abravanel F, Saune K, Miedouge M, Ellis V, Rech H, Destruel F, Kamar N, Dalton HR, Izopet J. 2011. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 17:2309-2312. http://dx.doi.org/10.3201/eid1712.110371.
20. Krumbholz A, Joel S, Dremsek P, Neubert A, Johne R, Durrwald R, Walther M, Muller TH, Kuhnel D, Lange J, Wutzler P, Sauerbrei A, Ulrich RG, Zell R. 2014. Seroprevalence of hepatitis E virus (HEV) in humans living in high pig density areas of Germany. Med Microbiol Immunol 203:273-282. http://dx.doi.org/10.1007/s00430-014-0336-3.
21. Kaba M, Davoust B, Marie JL, Barthet M, Henry M, Tamalet C, Raoult D, Colson P. 2009. Frequent transmission of hepatitis E virus among piglets in farms in southern France. J Med Virol 81:1750-1759. http://dx .doi.org/10.1002/jmv.21553.
22. Kaba M, Davoust B, Marie JL, Colson P. 2010. Detection of hepatitis E virus in wild boar (Sus scrofa) livers. Vet J 186:259-261. http://dx.doi.org/10.1016/j.tvjl.2009.08.008.
23. Carpentier A, Chaussade H, Rigaud E, Rodriguez J, Berthault C, Boue F, Tognon M, Touze A, Garcia-Bonnet N, Choutet P, Coursaget P. 2012. High hepatitis E virus seroprevalence in forestry workers and in wild boars in France. J Clin Microbiol 50:2888-2893. http://dx.doi.org/10 .1128/JCM.00989-12.
24. Kamar N, Abravanel F, Selves J, Garrouste C, Esposito L, Lavayssiere L, Cointault O, Ribes D, Cardeau I, Nogier MB, Mansuy JM, Muscari F, Peron JM, Izopet J, Rostaing L. 2010. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 89:353-360. http://dx.doi .org/10.1097/TP.0b013e3181c4096c.
25. Moal V, Motte A, Kaba M, Gerolami R, Berland Y, Colson P. 2013. Hepatitis E virus serological testing in kidney transplant recipients with elevated liver enzymes in 2007-2011 in southeastern France. Diagn Microbiol Infect Dis 76:116-118. http://dx.doi.org/10.1016/j.diagmicrobio .2013.02.017.
26. Agence de Biomédecine. 2014. Le rapport médical et scientifique de l'Agence de biomédecine 2013. Agence de Biomédecine, La Plaine Saint-Denis, France. http://www.agence-biomedecine.fr/annexes/bilan2013/accueil.htm.
27. Rossi-Tamisier M, Moal V, Gerolami R, Colson P. 2013. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 56:62-64. http://dx.doi.org/10.1016/j.jcv.2012.09.010.
28. Moal V, Gerolami R, Ferretti A, Purgus R, Devichi P, Burtey S, Colson P. 2014. Hepatitis E virus of subtype 3i in chronically infected kidney transplant recipients in southeastern France. J Clin Microbiol 52:3967-3972. http://dx.doi.org/10.1128/JCM.02028-14.
29. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. 2010. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEVIgG seroprevalence data in developed countries. J Med Virol 82:799-805. http://dx.doi.org/10.1002/jmv.21656.
30. Renou C, Roque-Afonso AM, Pavio N. 2014. Foodborne transmission of hepatitis E virus from raw pork liver sausage, France. Emerg Infect Dis 20:1945-1947. http://dx.doi.org/10.3201/eid2011.140791.
31. Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J, Dickinson S, Ellis V, Hunter JG, Prescott OR, Madden R, Lin NX, Henley WE, Bendall RP, Dalton HR. 2013. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol 85:266-271. http://dx.doi.org/10.1002/jmv.23463.
32. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, Farrington L, Hamad N, Sieberhagen C, Ellis V, Mitchell J, Hussaini SH, Banks M, Ijaz S, Bendall RP. 2008. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 20:784-790. http://dx.doi.org/10.1097/MEG.0b013e3282f5195a.
33. Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Kamar N, Izopet J. 2014. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis 209:1900-1906. http://dx.doi.org/10.1093/infdis/jiu032.
34. Buffaz C, Scholtes C, Dron AG, Chevallier-Queyron P, Ritter J, Andre P, Ramiere C. 2014. Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France. Eur J Clin Microbiol Infect Dis 33:1037-1043. http://dx.doi.org/10.1007/s10096-013-2042-2.
35. Sherman KE, Terrault N, Barin B, Rouster SD, Shata MT, HIV-TR Investigators. 2014. Hepatitis E infection in HIV-infected liver and kidney transplant candidates. J Viral Hepat 21:e74-e77. http://dx.doi.org/10 .1111/jvh.12233.
36. Renou C, Moreau X, Pariente A, Cadranel JF, Maringe E, Morin T, Causse X, Payen JL, Izopet J, Nicand E, Bourliere M, Penaranda G, Hardwigsen J, Gerolami R, Peron JM, Pavio N, ANGH, France. 2008. A national survey of acute hepatitis E in France. Aliment Pharmacol Ther 27:1086-1093. http://dx.doi.org/10.1111/j.1365-2036.2008.03679.x.
37. Sebode M, Pischke S, Lutgehetmann M, Polywka S, Quaas A, Lohse AW, Wege H. 2014. New foe treated with old guns-supportive role of steroids in the treatment of acute severe hepatitis E. BMC Gastroenterol 14:191. http://dx.doi.org/10.1186/s12876-014-0191-0.
38. Hewitt PE, Ijaz S, Brailsford SR, Brett R, Dicks S, Haywood B, Kennedy IT, Kitchen A, Patel P, Poh J, Russell K, Tettmar KI, Tossell J, Ushiro-Lumb I, Tedder RS. 2014. Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 384: 1766-1773. http://dx.doi.org/10.1016/S0140-6736(14)61034-5.
39. Colson P, Borentain P, Motte A, Moal V, Gerolami R. 2011. Hepatitis E virus as the most frequently identified cause of autochthonous acute hepatitis among adults in Marseille public hospitals. J Hepatol 54:S493-S494. http://dx.doi.org/10.1016/S0168-8278(11)61252-X.
40. Ministère des Affaires Sociales, de la Santé et des Droits des Femmes. 2011. Prévenir l'hépatite E chez les personnes susceptibles de développer une forme grave. Ministère des Affaires Sociales, de la Santé et des Droits des Femmes, Paris, France. http://www.sante.gouv.fr/IMG/pdf/Fiche-Hepatite-E.pdf.
41. Pickett BE, Sadat EL, Zhang Y, Noronha JM, Squires RB, Hunt V, Liu M, Kumar S, Zaremba S, Gu Z, Zhou L, Larson CN, Dietrich J, Klem EB, Scheuermann RH. 2012. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res 40:D593-D598. http://dx.doi.org/10.1093/nar/gkr859.